Market Overview
The MEA nasal drug delivery market was analyzed by Market Research Future (MRFR) and it was projected that a healthy CAGR of 8.1% will be attained by the market over the forecast period of 2015 to 2022. The valuation of the MEA nasal drug delivery market was further stated to surpass its previous valuation of USD 1 billion in 2015 to reach an estimated figure of USD 1.59 billion by the end of 2022.
The nasal drug delivery market in the Middle East and Africa region is moving at a healthy pace due to the number of advantages these drugs offer. Additionally, the increasing efficiency in the development of drugs that are easily absorbed from the nasal route, the east of administrating these drugs, and the increasing development of advanced products like metered dose pressurized containers are all influencing a positive scene in the market growth. However, the market growth can be constrained due to the low dose level of drugs and the irritation of the nasal route.
Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/2696
Market Segmentation
The MEA nasal drug delivery market has been segmented in terms of type, end-user, and components.
By dosage form, the market segments into ointments, sprays, drops, powder, and gels.
By systems, the market divides into metered dosage, unit dose, and multi-dose.
By delivery technologies, the market includes nebulizers, spray, and others.
By therapeutic applications, the market comprises vaccinations, congestion, rhinitis, and others.
Regional Analysis
The MEA nasal drug delivery market is geographically distributed across the following six major nations: the UAE, Kuwait, Saudi Arabia, Egypt, Qatar, and Oman. Among these countries, the market is spearheaded by the UAE. UAE contributes a major share to the MEA market due to the presence of a well-established healthcare infrastructure, growing availability of vaccinations and various other treatment options, high healthcare expenditure, and rising demand for advanced mode of drug administration in the nation.
Egypt holds the second largest share of the MEA nasal drug delivery market. This is majorly due to the growing awareness herein about the available treatment options for nasal-based infections. Additionally, this country has an established healthcare industry as it attracts a massive number of international tourists every single year, who require effective and proper healthcare facilities, and the expanding number of government initiatives undertaken to provide best-in-class healthcare solutions herein are pushing the growth of the Egyptian nasal drug delivery market.
Elsewhere, the lack of proper healthcare facilities and lack of awareness concerning nasal drugs in the remote and underdeveloped areas of the Africa region are spiraling a slow growth of the nasal drug delivery market in this region. However, growing support from the government towards providing better healthcare facilities in such areas owing to increasing medical needs among the population is leading the regional market towards growth and expansion.
Competitive Landscape
The MEA nasal drug delivery market comprises a host of key players. This includes names like Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG, Pfizer, Inc., AptarGroup Inc., Sanofi-Aventis, Becton Dickson & Company, GlaxoSmithKline PLC, and others.
The players of the MEA drug delivery market are majorly focused on expanding their business reach and penetrate the global audience by increasing their research-based expenditure for the development of new and advanced treatment solutions. Various key initiatives are being undertaken by the MEA players like strategically planning their mergers and acquisitions, one which is subsequently helping the players to maintain their market positioning and edge past their immediate competitors.
Browse Premium Research Report Enabled with Tables and Figures @ https://www.marketresearchfuture.com/reports/nasal-drug-delivery-market-2696
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/nasal-drug-delivery-market-2696